Technology needs
people and trust.

An attorney-at-law, senior associate in the corporate department of Rymarz Zdort Maruta and a member of its Life Sciences practice. He specialises in medical law, particularly regulations governing healthcare activities, patient rights, clinical trials and the legal aspects of telemedicine, e-health, artificial intelligence and healthcare innovation. He advises medical providers, pharmaceutical companies, healthcare IT suppliers, startups and public institutions. He works with organisations including the Telemedicine Working Group, the AI in Health Coalition and the NIL IN network, and coordinated work on the healthcare sector code of conduct approved by Poland’s data protection authority. He is a member of the Ombudsman’s Committee of Experts on Health, a lecturer and co-author of medical-law commentaries. He was named a Rising Star in 2023 and a key lawyer in the Legal 500 EMEA 2023 ranking.

An experienced executive and healthcare market expert with a long-standing career in Poland and internationally. He launched and managed the Polish subsidiaries of international pharmaceutical companies, including Laboratories Stiefel (now Glaxo Wellcome) and Laboratoires Dolisos (Pierre Fabre Group, now Boiron). He co-founded and formerly held shares in companies operating in clinical drug research and extracorporeal therapeutic blood purification. He previously served as management board representative and partner at DOM LEKARSKI S.A., and as president of the Innovative Medicine Association INKLAMED. He currently serves as Poland’s national coordinator for the HOPE Exchange programme for healthcare managers, run by the Polish Hospital Federation and the European Hospital and Healthcare Federation.